Labviva
founded 2017 and funded to $53.95 million, targeting regulated-industry procurement specifically — its February 2026 university programme is pitched at institutions navigating rising costs and funding cuts, and its June 2026 "Agentic Crew" release puts small language models behind compliant,…
- Country
- United States
US
Coverage
| CN | EU | US | |
|---|---|---|---|
| digital-it | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Lab-equipment management & procurement | digital-it | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.